By Phase II, when drug developers begin to understand their brands' clinical and commercial strengths and weaknesses, companies tend to spend more in line with their drug's commercial prospects or shortcomings.
-Jon Hess
Select a background
More quotes by Jon Hess
Popular Authors
A curated listing of popular authors.